The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation: The VENUS Randomized Clinical Trial
Open accessAbstract
Importance: Catheter ablation of persistent atrial fibrillation (AF) has limited success. Procedural strategies beyond pulmonary vein isolation have failed to consistently improve results. The vein of Marshall contains innervation and AF triggers that can be ablated by retrograde ethanol infusion. Objective: To determine whether vein of Marshall ethanol infusion could improve ablation results in persistent AF when added to catheter ablation. Design, Setting, and Participants: The Vein of Marshall Ethanol for Untreated Persistent AF (VENUS) trial was an investigator-initiated, National Institutes of Health-funded, randomized, single-blinded trial conducted in 12 centers in the United States. Patients (N = 350) with persistent AF referred for first ablation were enrolled from October 2013 through June 2018. Follow-up concluded in June 2019. Interventions: Patients were randomly assigned to catheter ablation alone (n = 158) or catheter ablation combined with vein of Marshall ethanol infusion (n = 185) in a 1:1.15 ratio to accommodate for 15% technical vein of Marshall ethanol infusion failures. Main Outcomes and Measures: The primary outcome was freedom from AF or atrial tachycardia for longer than 30 seconds after a single procedure, without antiarrhythmic drugs, at both 6 and 12 months. Outcome assessment was blinded to randomization treatment. There were 12 secondary outcomes, including AF burden, freedom from AF after multiple procedures, perimitral block, and others. Results: Of the 343 randomized patients (mean [SD] age, 66.5 [9.7] years; 261 men), 316 (92.1%) completed the trial. Vein of Marshall ethanol was successfully delivered in 155 of 185 patients. At 6 and 12 months, the proportion of patients with freedom from AF/atrial tachycardia after a single procedure was 49.2% (91/185) in the catheter ablation combined with vein of Marshall ethanol infusion group compared with 38% (60/158) in the catheter ablation alone group (difference, 11.2% [95% CI, 0.8%-21.7%]; P = .04). Of the 12 secondary outcomes, 9 were not significantly different, but AF burden (zero burden in 78.3% vs 67.9%; difference, 10.4% [95% CI, 2.9%-17.9%]; P = .01), freedom from AF after multiple procedures (65.2% vs 53.8%; difference, 11.4% [95% CI, 0.6%-22.2%]; P = .04), and success achieving perimitral block (80.6% vs 51.3%; difference, 29.3% [95% CI, 19.3%-39.3%]; P < .001) were significantly improved in vein of Marshall-treated patients. Adverse events were similar between groups. Conclusions and Relevance: Among patients with persistent AF, addition of vein of Marshall ethanol infusion to catheter ablation, compared with catheter ablation alone, increased the likelihood of remaining free of AF or atrial tachycardia at 6 and 12 months. Further research is needed to assess longer-term efficacy. Trial Registration: ClinicalTrials.gov Identifier: NCT01898221.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins
Haïssaguerre, M., Jaïs, P., Shah, D. C., Takahashi, A., Hocini, M., Quiniou, G., Garrigue, S., Le Mouroux, A., Le Métayer, P., & Clémenty, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809033391003 · Cited by 7,975
Calkins, H., Hindricks, G., Cappato, R., Kim, Y.-H., Saad, E. B., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, J., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.05.012 · Cited by 2,755
Self-citationApproaches to catheter ablation for persistent atrial fibrillation
Verma, A., Jiang, C.-Y., Betts, T. R., Chen, J., Deisenhofer, I., Mantovan, R., Macle, L., Morillo, C. A., Haverkamp, W., Weerasooriya, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408288 · Cited by 2,339
Self-citationSurgical ablation of atrial fibrillation during mitral-valve surgery
Gillinov, A. M., Gelijns, A. C., Parides, M. K., DeRose, J. J., Moskowitz, A. J., Voisine, P., Ailawadi, G., Bouchard, D., Smith, P. K., Mack, M. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500528 · Cited by 490
Catheter Ablation of Long-Standing Persistent Atrial Fibrillation
Tilz, R. R., Rillig, A., Thum, A.-M., Arya, A., Wohlmuth, P., Metzner, A., Mathew, S., Yoshiga, Y., Wissner, E., Kuck, K.-H., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.060 · Cited by 469
Pulmonary Vein Isolation Versus Defragmentation
Vogler, J., Willems, S., Sultan, A., Schreiber, D., Lüker, J., Servatius, H., Schäffer, B., Moser, J., Hoffmann, B. A., & Steven, D. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.09.088 · Cited by 349
Randomized Ablation Strategies for the Treatment of Persistent Atrial Fibrillation: RASTA Study
Dixit, S., Marchlinski, F. E., Lin, D., Callans, D. J., Bala, R., Riley, M. P., Garcia, F. C., Hutchinson, M. D., Ratcliffe, S. J., Cooper, J. M., et al. (2012) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.111.966226 · Cited by 281
Kim, D. T., Lai, A. C., Hwang, C., Fan, L.-T., Karagueuzian, H. S., Chen, P.-S., & Fishbein, M. C. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00819-6 · Cited by 268
Predictors of Non-Pulmonary Vein Ectopic Beats Initiating Paroxysmal Atrial Fibrillation
Lee, S.-H., Tai, C.-T., Hsieh, M.-H., Tsao, H.-M., Lin, Y.-J., Chang, S.-L., Huang, J.-L., Lee, K.-T., Chen, Y.-J., Cheng, J.-J., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.06.016 · Cited by 266
Lee, J. M., Shim, J., Park, J., Yu, H. T., Kim, T.-H., Park, J.-K., Uhm, J.-S., Kim, J.-B., Joung, B., Lee, M.-H., et al. (2019) · JACC: Clinical Electrophysiology · doi:10.1016/j.jacep.2019.08.021 · Cited by 206
Cited by
Tzeis, S., Gerstenfeld, E. P., Kalman, J., Saad, E. B., Shamloo, A. S., Andrade, J. G., Barbhaiya, C. R., Baykaner, T., Boveda, S., Calkins, H., et al. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.03.017 · Cited by 298
Self-citation
Metadata
- Authors
- Valderrábano, M., Peterson, L. E., Swarup, V., Schurmann, P. A., Makkar, A., Doshi, R. N., DeLurgio, D., Athill, C. A., Ellenbogen, K. A., Natale, A., Koneru, J., Dave, A. S., Giorgberidze, I., Afshar, H., Guthrie, M. L., Bunge, R., Morillo, C. A., & Kleiman, N. S.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2020-10-27
- Volume
- 324
- Issue
- 16
- Pages
- 1620
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W3094363855
- Cited by
- 368
- References
- 18
- FWCI
- 19.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation: The VENUS Randomized Clinical Trial. https://app.cochat.ai/papers/10.1001/jama.2020.16195
- The paper
- Valderrábano, M., Peterson, L. E., Swarup, V., Schurmann, P. A., Makkar, A., Doshi, R. N., DeLurgio, D., Athill, C. A., Ellenbogen, K. A., Natale, A., Koneru, J., Dave, A. S., Giorgberidze, I., Afshar, H., Guthrie, M. L., Bunge, R., Morillo, C. A., & Kleiman, N. S. (2020). Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation: The VENUS Randomized Clinical Trial. JAMA. https://doi.org/10.1001/jama.2020.16195
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.